Bloodstream Infection Testing Market Size

Bloodstream Infection Testing Market Size

Bloodstream Infection Testing Market size was valued at around USD 875.1 million in 2023 and is estimated to expand at 4.9% CAGR from 2024 to 2032. Bloodstream infections, also known as bacteremia or sepsis, it is diagnostic procedures and laboratory tests that are performed to identify the presence of bacteria or other microorganisms in the bloodstream.

To get key market trends

  Download Free Sample

The global rise in the prevalence of infectious diseases, coupled with growing awareness and increasing emphasis on infectious disease diagnostics, stands as key factors propelling the market growth. High population density and limited adherence to hygiene practices increases risk of infectious diseases, that significantly impact the human health. According to the data published by National Institutes of Health in 2022, approximately 250,000 bloodstream infections occur annually across the globe. Thus, increasing prevalence of several infectious diseases is anticipated to impel the market progression.
 

Technological advancements in bloodstream infection testing have significantly enhanced the accuracy, speed, and efficiency of diagnostic processes. Further, advances in molecular diagnostic techniques, such as polymerase chain reaction (PCR) technologies and nucleic acid amplification, enable the direct detection of microbial DNA or RNA, allowing for rapid and specific identification of pathogens. Therefore, technological advancements in bloodstream infection testing are projected to accelerate the market expansion.